+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Ocular Trauma Devices Market Size, Share & Industry Trends Analysis Report By End-Use, By Type (Implants, Instruments, and Disposables), By Indication (Blunt Trauma, Chemical Trauma, and Sharp Trauma), By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 86 Pages
  • November 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5709475
The Latin America, Middle East and Africa Ocular Trauma Devices Market should witness market growth of 8.8% CAGR during the forecast period (2022-2028).

Serious eye trauma necessitates pricy hospitalization, specialized care, and frequently extended follow-up and vision rehabilitation. Forthe medical system and the patient, this comes at a huge financial cost. Therefore, it is crucial to design effective prevention and management plans as well as a deeper understanding of the regional patterns of ocular injuries.

For badly injured eyes, surgical procedures are typically required. In comparison to eyes with a limbal path, eyes with IOFBs isolated from the entryway wound route can haveimproved visual outcomes. Especially in comparison to the pars plana path, the entrance wound path also enables bigger intraocular foreign body removal.

Ocular trauma shows a seasonal pattern, increasing in the autumn and summer and commencing around the start of the school year. As traumatic occurrences are more likely to necessitate surgical intervention, more cases turn up in July that needs effective management of ocular injuries to prevent blindness.

Blindness and monocular vision impairment are frequently caused by ocular trauma in this region. Between 34.3% and 76.6% of people in Ghana and Ethiopia are monocularly blind, according to several studies. Though those who have monocular blindness are not regarded as being legally blind, these wounds are important because they have an impact on the binocular visual field, the cosmoses, stereopsis, and on the sufferers' future professional lives.

The Brazil market dominated the LAMEA Ocular Trauma Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $76.9 Million by 2028. The Argentina market is experiencing a CAGR of 9.4% during (2022-2028). Additionally, The UAE market would display a CAGR of 8.5% during (2022-2028).

Based on End-Use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on Type, the market is segmented into Implants, Instruments, and Disposables. Based on Indication, the market is segmented into Blunt Trauma, Chemical Trauma, and Sharp Trauma. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Glaukos Corporation, Alcon, Inc., EssilorLuxottica SA (Essilor Instruments USA), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Carl Zeiss AG, Topcon Corporation, CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Hoya Corporation.

Scope of the Study

By End-Use

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Type

  • Implants
  • Instruments
  • Disposables

By Indication

  • Blunt Trauma
  • Chemical Trauma
  • Sharp Trauma

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
  • Glaukos Corporation
  • Alcon, Inc.
  • EssilorLuxottica SA (Essilor Instruments USA)
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Carl Zeiss AG
  • Topcon Corporation
  • CooperVision, Inc. (THE COOPER COMPANIES, INC.)
  • Hoya Corporation

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Ocular Trauma Devices Market, by End-Use
1.4.2 LAMEA Ocular Trauma Devices Market, by Type
1.4.3 LAMEA Ocular Trauma Devices Market, by Indication
1.4.4 LAMEA Ocular Trauma Devices Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Ocular Trauma Devices Market by End-Use
3.1 LAMEA Hospitals Market by Country
3.2 LAMEA Ophthalmic Clinics Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Ocular Trauma Devices Market by Type
4.1 LAMEA Implants Market by Country
4.2 LAMEA Instruments Market by Country
4.3 LAMEA Disposables Market by Country
Chapter 5. LAMEA Ocular Trauma Devices Market by Indication
5.1 LAMEA Blunt Trauma Market by Country
5.2 LAMEA Chemical Trauma Market by Country
5.3 LAMEA Sharp Trauma Market by Country
Chapter 6. LAMEA Ocular Trauma Devices Market by Country
6.1 Brazil Ocular Trauma Devices Market
6.1.1 Brazil Ocular Trauma Devices Market by End-Use
6.1.2 Brazil Ocular Trauma Devices Market by Type
6.1.3 Brazil Ocular Trauma Devices Market by Indication
6.2 Argentina Ocular Trauma Devices Market
6.2.1 Argentina Ocular Trauma Devices Market by End-Use
6.2.2 Argentina Ocular Trauma Devices Market by Type
6.2.3 Argentina Ocular Trauma Devices Market by Indication
6.3 UAE Ocular Trauma Devices Market
6.3.1 UAE Ocular Trauma Devices Market by End-Use
6.3.2 UAE Ocular Trauma Devices Market by Type
6.3.3 UAE Ocular Trauma Devices Market by Indication
6.4 Saudi Arabia Ocular Trauma Devices Market
6.4.1 Saudi Arabia Ocular Trauma Devices Market by End-Use
6.4.2 Saudi Arabia Ocular Trauma Devices Market by Type
6.4.3 Saudi Arabia Ocular Trauma Devices Market by Indication
6.5 South Africa Ocular Trauma Devices Market
6.5.1 South Africa Ocular Trauma Devices Market by End-Use
6.5.2 South Africa Ocular Trauma Devices Market by Type
6.5.3 South Africa Ocular Trauma Devices Market by Indication
6.6 Nigeria Ocular Trauma Devices Market
6.6.1 Nigeria Ocular Trauma Devices Market by End-Use
6.6.2 Nigeria Ocular Trauma Devices Market by Type
6.6.3 Nigeria Ocular Trauma Devices Market by Indication
6.7 Rest of LAMEA Ocular Trauma Devices Market
6.7.1 Rest of LAMEA Ocular Trauma Devices Market by End-Use
6.7.2 Rest of LAMEA Ocular Trauma Devices Market by Type
6.7.3 Rest of LAMEA Ocular Trauma Devices Market by Indication
Chapter 7. Company Profiles
7.1 Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent Strategies and Developments
7.1.5.1 Approvals and Trials
7.1.6 SWOT Analysis
7.2 Glaukos Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments
7.2.5.1 Approvals and Trials
7.3 Alcon, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent Strategies and Developments
7.3.5.1 Approvals and Trials
7.3.5.2 Acquisition and Mergers
7.4 EssilorLuxottica SA (Essilor Instruments USA)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Carl Zeiss AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Topcon Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 CooperVision, Inc. (THE COOPER COMPANIES, INC.)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Hoya Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses

Companies Mentioned

  • Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
  • Glaukos Corporation
  • Alcon, Inc.
  • EssilorLuxottica SA (Essilor Instruments USA)
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Carl Zeiss AG
  • Topcon Corporation
  • CooperVision, Inc. (THE COOPER COMPANIES, INC.)
  • Hoya Corporation

Methodology

Loading
LOADING...